Outsourcing

Feb 02, 2018
Pharmaceutical Technology
Mark Egerton, PhD, chief executive officer of Quotient Sciences, shares insights on a new approach to accelerate drug development, which integrates formulation development, real-time adaptive GMP manufacturing, and clinical research within a single platform.
Feb 02, 2018
Pharmaceutical Technology
Hospitals form not-for-profit drug company to combat drug shortages and high prices.
Feb 02, 2018
Pharmaceutical Technology
Layout and supply details must be considered when implementing a fully disposable biopharmaceutical manufacturing process.
Feb 01, 2018
Pharmaceutical Technology
Joe DiMasi, director of economic analysis and research associate professor, Tufts Center for the Study of Drug Development (CSDD), discussed research into the impacts of working with single source contractors with Pharmaceutical Technology.
Feb 01, 2018
Pharmaceutical Technology
Research suggests that working with a single contract partner can reduce development time and improve economics.
Feb 01, 2018
Pharmaceutical Technology
This article describes how to improve the regulatory journey from classification to market clearance for sponsors of medical device combination products.
Feb 01, 2018
Pharmaceutical Technology
CRLs put the brakes on drug development and damage corporate reputation and stock prices. Upfront investment and better sponsor oversight are ways to prevent them.
Feb 01, 2018
Pharmaceutical Technology
Successful outsourcing relationships in early phase drug-development analytics are driven by partnership.
Feb 01, 2018
Pharmaceutical Technology
A different perspective on controlling fixed costs of biomanufacturing, based on know-how from other industries, provides a competitive edge, says the CEO of Samsung BioLogics.
Feb 01, 2018
Pharmaceutical Technology
Chemical engineers and chemists each bring unique skills to API process development and optimization. Success depends on their close collaboration, at both sponsor and CDMO facilities.
native1_300x100
lorem ipsum